NUTRIEN LTD. (NTR): what the price assumes

boothcheck covers NUTRIEN LTD. (NTR) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed 2026-06-27.

Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/NTR

Headline

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

The operating-margin figure is value-band context at year 10: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

The price sits below what even a 5%/yr operating-profit decline would warrant; the inversion reports a bound, not a solved growth path.

Solve inputs: computed at a 7.4% cost of capital with 4% terminal growth over a 5-year stage.

Reconcile: at the x-ray's 9.3% required return this reads ~0%/yr; the models below use their own rates.

How unusual the bet is: within-range (limited comparison data)

Valuation X-Ray

The price is supported by earnings-power and relative-multiple and growth-DCF value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Families that justify the price: Earnings, Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.4%); the inversion above states its own rate.

Per-Model Detail (n=19)

Solvency

Bullet Takeaways

• Nutrien is the world's largest crop-nutrient company, mining and making potash and nitrogen fertilizer and also running the largest agricultural retail network, which sells seed, chemicals, and services directly to farmers.
• The defining tension is the cycle: first-quarter 2026 potash and nitrogen earnings rose on higher global benchmarks and record potash volumes, but fertilizer prices are commodity-driven, so today's strong margins are not guaranteed to last.
• The next markers are full-year production against the maintained guidance (14.1 to 14.7 million tonnes of potash, 9.2 to 9.7 million of nitrogen) and the retail EBITDA guide of $1.75 to $1.95 billion, the segment meant to steady the commodity swings.

Bull Case

What a simple earnings multiple misses about Nutrien is that it is two different businesses bolted together, and the market tends to price the whole thing as if it were only the cyclical commodity half. One half mines potash and manufactures nitrogen, the irreplaceable inputs that feed the world's crops, where Nutrien sits at the low end of the global cost curve with some of the best ore bodies and gas-advantaged plants. The other half is the largest agricultural retail network on the planet, selling seed, crop protection, and advisory services directly to farmers through thousands of locations. That retail arm earns steadier, fee-and-margin-based money that smooths the commodity cycle, and management guides it to $1.75 billion to $1.95 billion of EBITDA for the year with high-single-digit growth in proprietary-product margins.

The first quarter showed the commodity half firing. Potash adjusted EBITDA rose to $578 million on higher global benchmarks and record sales volumes, and nitrogen adjusted EBITDA rose to $482 million, lifting total adjusted EBITDA to $1.11 billion. Record potash volumes matter because Nutrien's low-cost mines mean each incremental tonne carries high incremental margin, and the company can flex production to meet demand better than higher-cost competitors. Global food demand grows steadily while arable land does not, which is the long-run tailwind under the whole business.

The capital return is the tangible payoff and the evidence the assets generate real cash. Nutrien returned $409 million to shareholders in the quarter through its dividend, which yields around 3.1%, and buybacks, and the share count has fallen about 3.9% a year. A cyclical that shrinks its share base meaningfully through the cycle compounds per-share value even when prices are only average. Every valuation method, asset value, earnings power, peer multiples, and growth-discounted cash flow, supports today's price, which is the market acknowledging the business is reasonably valued rather than stretched. The bull case is that Nutrien is a low-cost, irreplaceable-input franchise with a stabilizing retail arm, trading at a low-double-digit multiple while returning cash.

Bear Case

The valuation methods all support Nutrien's price, and for a commodity producer that unanimous support is the warning, not the reassurance. The methods are reading the current, elevated fertilizer earnings as if they were the run rate, and the iron rule of cyclicals is that peak earnings are not sustainable earnings. Potash and nitrogen prices are set by global supply and demand, not by Nutrien, and the first-quarter strength came specifically from higher global benchmarks. Benchmarks that rise can fall: new low-cost supply, a strong harvest that depresses crop prices and farmer spending, or a shift in global trade flows can all push fertilizer prices down, and Nutrien's earnings fall with them. A multiple that looks cheap on peak earnings looks expensive on trough earnings, and the static methods cannot tell the difference.

The nitrogen business adds a specific exposure: natural gas. Gas is the primary feedstock for making nitrogen fertilizer, so a spike in gas prices, particularly in regions where Nutrien's plants are not gas-advantaged, compresses nitrogen margins directly. The company is also exposed to the farm economy as a whole: when crop prices are weak and farm incomes fall, farmers cut back on fertilizer application and on the discretionary products Nutrien's retail arm sells, so the retail buffer is not fully insulated from the same cycle that drives the commodity half.

The balance sheet carries real debt, about $10 billion net, which is manageable in good years but a constraint in bad ones. Interest is covered comfortably when fertilizer prices are high, but the coverage compresses as earnings fall, and a leveraged cyclical at the wrong point in the cycle has less room to fund its dividend and buyback at once. The bear case is not that Nutrien is a poor business; it is that an investor buying at today's price is implicitly underwriting fertilizer prices staying near current levels, and the history of commodities says they will not stay anywhere for long. The cheapness is real only if the cycle holds.

Valuation

Nutrien reads as a value-and-asset-supported name, with every method, asset value, earnings power, peer multiples, and the growth-discounted lens, supporting today's price near $63 (June 27, 2026), and none calling it expensive. At roughly 11 times blended earnings, the price is not asking for growth; it is pricing the existing earnings power of a low-cost fertilizer producer plus the largest agricultural retail network. The implied assumption is modest, which is exactly what you would expect for a mature, cash-generative cyclical.

The caveat is the one that governs every commodity name: the earnings the methods are capitalizing are cyclical. First-quarter potash and nitrogen results rode higher global benchmarks and record potash volumes, and a multiple that looks cheap against those earnings would look richer if benchmarks normalized lower. The right way to read Nutrien is through the cycle, not at a single point in it: the low-cost potash mines and the retail arm's steadier EBITDA, guided to $1.75 billion to $1.95 billion, are the through-cycle anchors, while the commodity benchmarks are the swing factor. The methods support the price on current earnings; the judgment is whether those earnings sit near mid-cycle or above it.

Solvency is sound but not trivial. Nutrien carries about $10 billion of net debt, with interest covered comfortably at current earnings levels, and the share count has fallen about 3.9% a year as buybacks return capital alongside a dividend yielding around 3.1%. The leverage is normal for the sector and well within the company's cash generation in a typical year, but it tightens as the cycle turns down. The bet the buyer underwrites is that fertilizer earnings hold near current levels long enough for the low multiple and the capital return to compound, with the retail arm cushioning the commodity swings. The assets are genuinely irreplaceable; the earnings that value them are not fixed.

Catalysts

The first quarter of 2026 was strong on the commodity side. Nutrien reported net earnings of $139 million, or $0.27 per diluted share, with adjusted EBITDA of $1.11 billion and adjusted net earnings of $0.51 per share. Potash adjusted EBITDA rose to $578 million on higher global benchmarks and record sales volumes, nitrogen adjusted EBITDA reached $482 million on higher benchmarks, and retail adjusted EBITDA was $108 million.

Management reaffirmed full-year 2026 guidance, maintaining potash production of 14.1 million to 14.7 million tonnes and nitrogen of 9.2 million to 9.7 million tonnes, the latter inclusive of planned turnarounds at three nitrogen facilities, and held retail EBITDA guidance at $1.75 billion to $1.95 billion with high-single-digit growth projected in proprietary-product gross margin. The company returned $409 million to shareholders in the quarter through dividends and buybacks, with the dividend yielding around 3.1%.

The markers to watch are the commodity benchmarks above all: potash and nitrogen prices set the earnings, and their direction over the coming quarters matters more than any single operating metric. Alongside them, the strength of the farm economy and crop prices drives both fertilizer application rates and the retail arm's discretionary sales, and natural gas costs feed directly into nitrogen margins. Each tells you whether the current earnings are near a sustainable mid-cycle level or riding a peak that the price has not yet discounted.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

• LYB (LYONDELLBASELL INDUSTRIES N.V.)
• FY2025 10-K: …primarily by either truck or bulk rail. Sales for the APS segment accounted for approximately 11% of our consolidated revenues in 2025, 2024, and 2023. Joint Venture Relationships -We participate in several manufacturing joint ventures in Saudi Arabia, Indonesia and Thailand. We hold majority interests and have…
• FY2025 10-K: …well as smaller specialty applications. Our customers use our plastics and chemicals to manufacture a wide range of products that people use in their everyday lives, including food packaging, home furnishings, automotive components, paints and coatings. We also develop and license chemical and polyolefin process…
• SW (Smurfit Westrock plc)
• FY2025 10-K: …to the demand requirements of both internal and external converters located within an economically reasonable shipping distance from each mill, thereby minimizing logistics costs. Our strategy for the corrugated container and other converting plants focuses on both customized products tailored to fit customers' needs…
• FY2025 10-K: …or cost- effective manner. Higher transportation costs could make our products less competitive compared to similar or alternative products offered by competitors. 26 The failure to obtain raw materials, energy or transportation services at reasonable market prices (or the failure to pass on price increases to…
• LIN (LINDE PLC)
• FY2025 10-K: …reporting purposes is segment operating profit. Segment operating profit is defined as operating profit excluding purchase accounting impacts of the Linde AG merger, cost reduction program and other charges, and items not indicative of ongoing business trends. This is the manner in which the company's Chief Operating…
• FY2025 10-K: …20 Segment Discussion 25 Liquidity, Capital Resources and Other Financial Data 30 Off-Balance Sheet Arrangements 32 Critical Accounting Estimates 32 New Accounting Standards 34 Fair Value Measurements 34 Non-GAAP Financial Measures 35 Supplemental Guarantee Information 38 17 Table of Contents BUSINESS OVERVIEW The…
• DOW (Dow Inc.)
• FY2025 10-K: …Consumer Solutions consists of two businesses: Performance Silicones & Specialty Materials and Silicone Feedstocks & Intermediates. The Performance Silicones & Specialty Materials business delivers a comprehensive portfolio of performance-enhancing products to meet the diverse needs of customers in high-growth…
• FY2025 10-K: …were primarily related to the Company's insurance operations and licensing of patents and technologies. Disaggregation of Revenue Dow disaggregates its revenue from contracts with customers by operating segment and business, as the Company believes it best depicts the nature, amount, timing and uncertainty of its…
• KMB (KIMBERLY-CLARK CORPORATION)
• FY2025 10-K: Baby and Child Care and Family Care categories. Increased purchases of private label products could reduce net sales of our higher-margin products which would negatively impact our profitability. While the global marketplace in which we operate has always been highly competitive, we continue to experience increased…
• FY2025 10-K: …included approximately 130 basis points and 85 basis points, respectively, for charges related to the 2024 Transformation Initiative, primarily for incremental depreciation expense, workforce reductions and asset write-offs. Excluding these charges, adjusted gross margin was 37.3%, a decrease of 100 basis points…
• PPG (PPG INDUSTRIES INC)
• FY2025 10-K: …customers' operations that support their global expansion, sustainability and productivity goals. Further information related to the three reportable business segments is summarized below. 2025 PPG ANNUAL REPORT AND FORM 10-K 3 GLOBAL ARCHITECTURAL COATINGS Strategic Business Unit Products Primary Customers /…
• FY2025 10-K: …diversity of the business portfolio, as the Company benefited from higher prices and sales volumes in several businesses and favorable foreign currency translation, which was offset by the impact of divestitures completed in 2024. Net sales, excluding the impact of currency, acquisitions and divestitures ("organic…
• APD (AIR PRODUCTS AND CHEMICALS, INC.)
• FY2025 10-K: …natural gas, and hydrocarbon price fluctuations contractually through pricing formulas, surcharges, cost pass-through provisions, and tolling arrangements. Each of the regional industrial gases segments competes against global industrial gas companies as well as regional competitors. Competition in industrial gases…
• FY2025 10-K: …with certain components procured from subcontractors and vendors. Competition in the equipment business is based primarily on plant efficiency and technological performance, service, technical know-how, and price, as well as schedule and plant performance guarantees. Our sale of equipment supply mode constituted less…
• PX (PX)
• (no filing in the citation store)

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.